FDA approval allows market entry for devices from Dexcom and Intuitive Surgical.
2 reports, 2 independent
Updated Jul 28
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA approval allows market entry for devices from Dexcom and Intuitive Surgical.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Dexcom
company that develops, manufactures and distributes continuous glucose monitoring systems
-
Intuitive Surgical
American corporation
Related events
- FDA approval enables commercial availability for a product associated with Indianapolis.
- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
- Unregulated products are bypassing official government approval processes.
- FDA approval expands patient access to therapies for ACCORD.
- Arise is seeking FDA approval for a drug as of October 7, 2026.
Coverage
Newest first; wire copies grouped- fool.comHere's Exactly Why Wall Street Thinks Intuitive Surgical Stock Could Soar 102% Over the Next 12 Months | The Motley Fool
- financialcontent.com